Copyright © 2005, The European Society of Cardiology
Dobutamine stress echocardiography and cardiac troponin T for the detection of significant coronary artery disease and predicting outcome in renal transplant candidates
aDepartment of Cardiology, St George's Hospital, London, UK
bThe Heart Hospital, London, UK
cDepartment of Chemical Pathology, St George's Hospital, London, UK
dDepartment of Renal Medicine, St George's Hospital, London, UK
Received 27 October 2004; received in revised form 20 April 2005; accepted after revision 27 April 2005.
rsharma{at}tinyworld.co.uk
* Corresponding author. Department of Cardiology, E Level East Wing, Mailpoint 46, Southampton General Hospital, Tremona Road, Southampton SO16 6YD, UK. Tel.: +44 781 448 2140.
 |
Abstract |
|---|
Aims
Ischaemic heart disease is the leading cause of mortality and morbidity in patients with end-stage renal disease (ESRD) and after renal transplantation. However, the optimal non-invasive test for coronary artery disease (CAD) diagnosis in this population has yet to be established. The aim of this study was to assess the diagnostic accuracy of dobutamine stress echocardiography (DSE) and baseline plasma cardiac troponin T (cTnT) for detecting significant CAD and predicting adverse cardiac events in patients referred for renal transplantation.
Methods
Coronary angiography, DSE, and baseline cTnT measurements were performed in 118 consecutive patients (mean age 52±12 years, 75 male) with ESRD (mean creatinine 608±272µmol/L) referred for renal transplantation. The mean follow-up period was 1.32±0.48 years. Significant CAD was defined as a reduction in luminal diameter >70% by visual estimation in at least one major epicardial vessel. An abnormal DSE result defined as the development of a new regional wall motion abnormality in one or more normal resting segments or a deterioration of wall motion in one or more resting hypokinetic segments. A baseline cTnT>0.1µg/L was taken as positive.
Results
Significant CAD in at least one vessel was present in 35 patients (30%). The number of patients with significant 3 vessel and 2 vessel disease was 6 and 7, respectively. An abnormal DSE result was present in 36 (31%) patients. Thirty-one (26%) had cTnT>0.1µg/L. Sixty-four (54%) patients were on dialysis and 46 (39%) were diabetic. The sensitivity, specificity, positive and negative predictive values for DSE in detecting significant coronary artery disease were 88%, 94%, 86% and 95%, respectively. The same values for a raised cTnT were 54%, 62%, 40% and 74%, respectively. The combination of an abnormal DSE result and raised cTnT gave values of 61%, 91%, 76%, and 80%, respectively. Over the follow-up period, mortality was significantly higher in those with a raised baseline cTnT but not those with an abnormal DSE result or significant CAD.
Conclusion
DSE is an accurate technique for the detection of significant CAD in renal transplant candidates. An elevated cTnT does not predict significant CAD in this population and when used in conjunction with DSE, reduces the sensitivity of the combined tests. cTnT is an important marker of prognosis in renal transplant candidates.
Keywords: End stage renal disease; Dobutamine stress echocardiography; Cardiac troponin T; Coronary artery disease
CiteULike 
Connotea 
Del.icio.us What's this?
Related articles in Eur J Echocardiogr:
- Ischemic heart disease in renal transplant candidates: Towards non-invasive approaches for preoperative risk stratification
- H.H.H. Feringa, J.J. Bax, O. Schouten, and D. Poldermans
Eur J Echocardiogr 2005 6: 313-316.[Abstract] [Full Text]
This article has been cited by other articles:
|
|
 |
|
  L. H. Jacobs, J. J. van de Kerkhof, A. M. Mingels, V. L. Passos, V. W. Kleijnen, A. H. Mazairac, F. M. van der Sande, W. K. Wodzig, C. J. Konings, K. M. Leunissen, et al. Inflammation, overhydration and cardiac biomarkers in haemodialysis patients: a longitudinal study Nephrol. Dial. Transplant., January 1, 2010; 25(1): 243 - 248. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Herzog Kidney disease in cardiology Nephrol. Dial. Transplant., January 1, 2008; 23(1): 42 - 46. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Herzog Kidney disease in cardiology Nephrol. Dial. Transplant., January 1, 2007; 22(1): 43 - 46. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R Sharma, D C Gaze, D Pellerin, R L Mehta, H Gregson, C P Streather, P O Collinson, and S J D Brecker Raised plasma N-terminal pro-B-type natriuretic peptide concentrations predict mortality and cardiac disease in end-stage renal disease. Heart, October 1, 2006; 92(10): 1518 - 1519. [Full Text] [PDF]
|
|
|
|
 |
|
 M. N. Fahie-Wilson, D. J. Carmichael, M. P. Delaney, P. E. Stevens, E. M. Hall, and E. J. Lamb Cardiac Troponin T Circulates in the Free, Intact Form in Patients with Kidney Failure Clin. Chem., March 1, 2006; 52(3): 414 - 420. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. A. Abbas, R. I. John, M. C. Webb, M. E. Kempson, A. N. Potter, C. P. Price, S. Vickery, and E. J. Lamb Cardiac Troponins and Renal Function in Nondialysis Patients with Chronic Kidney Disease Clin. Chem., November 1, 2005; 51(11): 2059 - 2066. [Abstract] [Full Text] [PDF]
|
|